These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8105057)

  • 1. The effects of N-benzoyl-beta-alanine, a new nephroprotective drug, on the distribution and renal excretion of enprofylline in rats.
    Wang L; Hasegawa T; Nadai M; Nabeshima T
    J Pharm Pharmacol; 1993 Jul; 45(7):622-6. PubMed ID: 8105057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age on the disposition and renal handling of enprofylline in rats.
    Muraoka I; Hasegawa T; Nadai M; Wang L; Tagaya O; Nabeshima T
    J Pharm Pharmacol; 1994 Mar; 46(3):230-4. PubMed ID: 8027934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
    Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
    Drug Metab Dispos; 1993; 21(4):611-6. PubMed ID: 8104119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and renal handling of enprofylline in pregnant rats.
    Muraoka I; Hasegawa T; Nadai M; Kato K; Nabeshima T
    Drug Metab Dispos; 1992; 20(5):653-7. PubMed ID: 1358568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats.
    Nadai M; Hasegawa T; Wang L; Tagaya O; Nabeshima T
    Drug Metab Dispos; 1994; 22(4):561-5. PubMed ID: 7956730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent pharmacokinetics of enprofylline and its renal handling in rats.
    Nadai M; Hasegawa T; Muraoka I; Takagi K; Nabeshima T
    J Pharm Sci; 1991 Jul; 80(7):648-52. PubMed ID: 1941561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives.
    Tsunekawa Y; Hasegawa T; Nadai M; Takagi K; Nabeshima T
    J Pharm Pharmacol; 1992 Jul; 44(7):594-9. PubMed ID: 1357141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
    Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
    Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats.
    Nadai M; Hasegawa T; Wang L; Haghgoo S; Nabeshima T; Kato N
    Biol Pharm Bull; 1995 Aug; 18(8):1089-93. PubMed ID: 8535402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probenecid on enprofylline kinetics in man.
    Borgå O; Larsson R; Lunell E
    Eur J Clin Pharmacol; 1986; 30(2):221-3. PubMed ID: 3709650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ampicillin on the elimination of enprofylline in man.
    Paulsen O; Borgå O; Andersson KE
    Pharmacol Toxicol; 1987 May; 60(5):380-4. PubMed ID: 3615348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice.
    Nadai M; Hasegawa T; Wang L; Haghgoo S; Okasaka T; Nabeshima T; Kato N
    J Pharm Pharmacol; 1996 Jul; 48(7):744-8. PubMed ID: 8866341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease.
    Kraan J; Jonkman JH; Koëter GH; Gips CH; de Jong PE; van der Mark TW; Ekman I; de Zeeuw RA
    Eur J Clin Pharmacol; 1988; 35(4):357-62. PubMed ID: 3197743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats.
    Kuzuya T; Hasegawa T; Shiraki R; Nabeshima T
    Biol Pharm Bull; 1997 Oct; 20(10):1051-5. PubMed ID: 9353563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible mechanism of interaction between xanthines and quinolone.
    Hasegawa T; Nadai M; Kuzuya T; Muraoka I; Apichartpichean R; Takagi K; Miyamoto K
    J Pharm Pharmacol; 1990 Nov; 42(11):767-72. PubMed ID: 1982300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of enprofylline administered intravenously and as a sustained-release tablet at steady state in children with asthma.
    Watson WT; Simons KJ; Simons FE
    J Pediatr; 1988 Apr; 112(4):658-62. PubMed ID: 3351694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enprofylline disposition in the presence and absence of amoxycillin or erythromycin.
    Sitar DS; Aoki FY; Hoban DJ; Hidinger KG; Montgomery PR; Mitenko PA
    Br J Clin Pharmacol; 1987 Jul; 24(1):57-61. PubMed ID: 3620286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous infusion of enprofylline with an exponentially decreasing drug concentration in acute asthma.
    Arnman K; Willén B; Borgström L; Conradson TB
    Ther Drug Monit; 1989; 11(3):249-52. PubMed ID: 2728082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enprofylline kinetics in healthy subjects after single doses.
    Borgå O; Andersson KE; Edholm LE; Fagerström PO; Lunell E; Persson CG
    Clin Pharmacol Ther; 1983 Dec; 34(6):799-804. PubMed ID: 6641096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.
    Laursen LC; Johannesson N; Søndergaard I; Weeke B
    Br J Clin Pharmacol; 1984 Oct; 18(4):591-5. PubMed ID: 6487499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.